Indaptus Therapeutics (INDP) PEG Ratio
Market Cap: $6.51M
Avg Volume: 431.31K
Industry: Biotechnology
Sector: Healthcare
PEG Ratio Summary
- Indaptus Therapeutics's trailing twelve month (TTM) PEG ratio is -0.04.
- Indaptus Therapeutics's annual PEG ratio as of today is 0.04.
- Indaptus Therapeutics's quarterly PEG ratio is -0.03.
What is the PEG Ratio?
The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.
How is the PEG Ratio calculated?
The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:
PEG Ratio = (P/E Ratio) / (EPS Growth Rate)
This helps investors to determine a stock's value while considering the company's earnings growth.
Related Metrics
Other important metrics to assess Indaptus Therapeutics's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -0.52
- Quarterly: -0.48
- TTM: -0.28
- P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
- Annual: 0.00
- Quarterly: 0.00
- TTM: 0.00
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 2.00
- Quarterly: 2.00
- TTM: 1.07
- P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -0.64
- Quarterly: -2.32
- TTM: -0.34
These metrics provide insights into Indaptus Therapeutics's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
TTM PEG Ratio
-0.04
Annual PEG Ratio
0.04
Quarterly PEG Ratio
-0.03
Indaptus Therapeutics Historical PEG Ratio
Historical P/E Ratio
Historical P/S Ratio
Historical P/B Ratio
Historical P/CF Ratio
Indaptus Therapeutics Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | PEG Ratio | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|---|
| 2024 | 0.04 | -0.52 | 0.00 | 2.00 | -0.64 |
| 2023 | -0.09 | -0.96 | 0.00 | 1.22 | -1.10 |
| 2022 | 0.07 | -0.87 | 0.00 | 0.49 | -0.92 |
| 2021 | 0.04 | -3.03 | 0.00 | 0.65 | -2.07 |
| 2020 | 0.02 | -1.88 | 0.00 | -28.23 | -2.02 |
| 2019 | -0.37 | -0.35 | 0.00 | 1.46 | -0.58 |
| 2018 | 0.37 | -5.40 | 0.00 | 4.39 | -6.02 |
| 2017 | -0.08 | -3.15 | 0.00 | 1.55 | -4.11 |
| 2016 | -0.18 | -4.88 | 0.00 | 2.87 | -5.44 |
| 2015 | 0.00 | -5.82 | 0.00 | 1.17 | -5.27 |
| 2014 | 483.02 | -254.22 | 0.00 | 152.76 | -304.64 |
| 2013 | 22.51 | -252.47 | 0.00 | 138.38 | -380.00 |
| 2012 | 5.64 | -224.00 | 0.00 | 169.47 | -257.87 |
| 2011 | -11.28 | -135.21 | 0.00 | 131.94 | -190.48 |
| 2010 | 14.49 | -151.44 | 0.00 | 71.37 | -190.57 |
Related Metrics
Explore detailed financial metrics and analysis for INDP.